Mizell Memorial Hospital, Inc. Family Medicine Medicare: Medicare Enrolled Practice Location: 918 Drayton Ave, Elba, AL 36323 Phone: 334-493-5713 |
Elba Physician Group Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 987 Drayton Ave, Elba, AL 36323 Phone: 334-897-2257 |
First Med Of Elba Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 252 Larkin Rd, Elba, AL 36323 Phone: 334-897-2207 Fax: 334-853-0128 |
Jason D. Tucker, Md Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 980 Drayton Ave, Elba, AL 36323 Phone: 334-897-3800 Fax: 334-897-3804 |
Joyce P. Goetsch, Md Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 980 Drayton Ave, Elba, AL 36323 Phone: 334-897-3800 Fax: 334-897-3804 |
Dr. Glenn Roberts Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 978 Drayton Ave, Elba, AL 36323 Phone: 334-897-2597 Fax: 334-897-6662 |
Lance K. Dyess, Md Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 918 Drayton Ave, Elba, AL 36323 Phone: 334-897-2207 Fax: 334-897-3476 |
News Archive
Though identifying data typically are removed from medical image files before they are shared for research, a Mayo Clinic study finds that this may not be enough to protect patient privacy.
Validic, the healthcare industry's leading digital health platform, announced today that it has secured a $12.5 million Series B round led by Kaiser Permanente Ventures, the corporate venture capital arm of Kaiser Permanente. The funding will continue to fuel Validic's rapid growth.
DNA methylation - a modification of DNA linked to gene regulation - is altered with increasing severity in a blood cancer called multiple myeloma, according to a study by Mayo Clinic and the Translational Genomics Research Institute (TGen).
Migraine is one of the most common neurological disorders and it affects 1 out of 7 people in the world. Painful and incapacitating, it has multi-factor origins, with the participation of environmental triggering factors and several altered genes in each individual.
A new British Journal of Clinical Pharmacology review examines the impact of cancer therapies on the skeleton and how to limit bone loss and fractures in cancer patients treated with these therapies.
› Verified 3 days ago